Skip to main content
. 2013 Oct 23;33(43):17023–17028. doi: 10.1523/JNEUROSCI.2124-13.2013

Table 2.

Change in BSS symptoms scores (post-treatment minus baseline)

BSS symptom Deletion
No deletion
ANOVA
PLC (N = 30)
RBX (N = 34)
PLC (N = 32)
RBX (N = 23)
ADRA2B × groupa
Mean SD Mean SD Mean SD Mean SD F p
Dizzinessb 3.80 11.18 6.59 11.91 0.63 5.43 14.00 15.83 6.60 0.01
Dry mouth −5.22 13.35 −1.17 18.85 −6.2 18.53 7.18 27.78 1.36 0.24
Anxietyb −7.23 10.63 0.76 11.96 −4.59 9.08 −4.70 11.58 3.87 0.05
Sweating −4.20 19.28 4.65 21.74 −4.56 13.44 1.61 11.36 0.06 0.80
Palpitations −2.00 4.40 0.74 10.23 −0.91 5.06 6.39 19.50 1.86 0.17
Nausea −1.43 5.59 8.41 16.65 −0.69 3.63 9.70 14.85 0.04 0.83
Irritabilityb −4.57 10.20 0.82 15.75 −0.03 6.35 −4.65 14.74 4.38 0.04
Tiredness −5.73 14.54 −7.29 17.66 −9.91 11.56 −7.83 21.29 0.41 0.52
Loss of concentration −4.07 19.06 −1.15 14.47 −4.06 8.81 0.52 15.88 0.27 0.60

aDegrees of freedom = 1, 112.

bp ≤ 0.05.